{
  "DOI": "10.1007/s10689-011-9498-y",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-011-9498-y",
  "alternative-id": [
    "9498"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Schneegans",
      "given": "S. M.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Rosenberger",
      "given": "A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Engel",
      "given": "U.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sander",
      "given": "M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Emons",
      "given": "G.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Shoukier",
      "given": "M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        12,
        12
      ]
    ],
    "date-time": "2011-12-12T05:14:37Z",
    "timestamp": 1323666877000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        6,
        20
      ]
    ],
    "date-time": "2019-06-20T15:52:23Z",
    "timestamp": 1561045943000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        15
      ]
    ],
    "date-time": "2024-04-15T22:28:46Z",
    "timestamp": 1713220126255
  },
  "is-referenced-by-count": 13,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2011,
        12,
        13
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2012,
          6
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "http://www.springerlink.com/index/pdf/10.1007/s10689-011-9498-y",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "181-188",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2011,
        12,
        13
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        12,
        13
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2012,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/caac.20107",
      "author": "A Jemal",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "issue": "2",
      "journal-title": "CA Cancer J Clin",
      "key": "9498_CR1",
      "unstructured": "Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90",
      "volume": "61",
      "year": "2011"
    },
    {
      "DOI": "10.1136/jech.2008.083774",
      "author": "K Zbuk",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "issue": "1",
      "journal-title": "J Epidemiol Community Health",
      "key": "9498_CR2",
      "unstructured": "Zbuk K, Anand SS (2012) Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries. J Epidemiol Community Health 66(1):1–7",
      "volume": "66",
      "year": "2012"
    },
    {
      "DOI": "10.1136/bmj.c3620",
      "author": "P Autier",
      "doi-asserted-by": "crossref",
      "first-page": "c3620",
      "journal-title": "BMJ",
      "key": "9498_CR3",
      "unstructured": "Autier P, Boniol M, La Vecchia C et al (2010) Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 341:c3620",
      "volume": "341",
      "year": "2010"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-10-0437",
      "author": "A Jemal",
      "doi-asserted-by": "crossref",
      "first-page": "1893",
      "issue": "8",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9498_CR4",
      "unstructured": "Jemal A, Center MM, DeSantis C, EM Ward (2010) Global patterns of cancer incidence, mortality rates, trends. Cancer Epidemiol Biomarkers Prev 19(8):1893–1907",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1086/301749",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "676",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "9498_CR5",
      "unstructured": "Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity, penetrance analysis of the BRCA1, BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676–689",
      "volume": "62",
      "year": "1998"
    },
    {
      "author": "JC Carroll",
      "first-page": "1691",
      "issue": "12",
      "journal-title": "Can Fam Physician",
      "key": "9498_CR6",
      "unstructured": "Carroll JC, Cremin C, Allanson J et al (2008) Hereditary breast and ovarian cancers. Can Fam Physician 54(12):1691–1692",
      "volume": "54",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ng.569",
      "author": "A Meindl",
      "doi-asserted-by": "crossref",
      "first-page": "410",
      "issue": "5",
      "journal-title": "Nat Genet",
      "key": "9498_CR7",
      "unstructured": "Meindl A, Hellebrand H, Wiek C et al (2010) Germline mutations in breast, ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42(5):410–414",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1186/1471-2350-12-9",
      "author": "V Stegel",
      "doi-asserted-by": "crossref",
      "first-page": "9",
      "journal-title": "BMC Med Genet",
      "key": "9498_CR8",
      "unstructured": "Stegel V, Krajc M, Zgajnar J et al (2011) The occurrence of germline BRCA1, BRCA2 sequence alterations in Slovenian population. BMC Med Genet 12:9",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s12687-011-0042-4",
      "author": "D Gadzicki",
      "doi-asserted-by": "crossref",
      "first-page": "53",
      "journal-title": "J Community Genet",
      "key": "9498_CR9",
      "unstructured": "Gadzicki D, Evans DG, Harris H et al (2011) Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, The Netherlands and Germany. J Community Genet 2:53–69",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1093/jnci/djq088",
      "author": "E Amir",
      "doi-asserted-by": "crossref",
      "first-page": "680",
      "issue": "10",
      "journal-title": "J Natl Cancer Inst",
      "key": "9498_CR10",
      "unstructured": "Amir E, Freedman OC, Seruga B, Evans DG (2010) Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 102(10):680–691",
      "volume": "102",
      "year": "2010"
    },
    {
      "DOI": "10.1159/000091305",
      "author": "B Kuschel",
      "doi-asserted-by": "crossref",
      "first-page": "8",
      "journal-title": "Breast Care",
      "key": "9498_CR11",
      "unstructured": "Kuschel B, Hauenstein E, Kiechle M, Meindl A (2006) Hereditary breast and ovarian cancer—current clinical guidelines in Germany. Breast Care 1:8–14",
      "volume": "1",
      "year": "2006"
    },
    {
      "DOI": "10.1186/1471-2350-8-13",
      "author": "H Katki",
      "doi-asserted-by": "crossref",
      "first-page": "13",
      "journal-title": "BMC Med Genet",
      "key": "9498_CR12",
      "unstructured": "Katki H (2007) Incorporating medical interventions into carrier probability estimation for genetic counseling. BMC Med Genet 8:13",
      "volume": "8",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-08-1090",
      "author": "AW Kurian",
      "doi-asserted-by": "crossref",
      "first-page": "1084",
      "issue": "4",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9498_CR13",
      "unstructured": "Kurian AW, Gong GD, John EM et al (2009) Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California breast cancer family registry. Cancer Epidemiol Biomarkers Prev 18(4):1084–1091",
      "volume": "18",
      "year": "2009"
    },
    {
      "author": "R Schmutzler",
      "first-page": "A1372",
      "journal-title": "Dtsch Arztebl",
      "key": "9498_CR14",
      "unstructured": "Schmutzler R, Beckmann M, Kiechle M (2002) Prevention: hereditary breast and ovarian cancer. Dtsch Arztebl 99:A1372–A1378",
      "volume": "99",
      "year": "2002"
    },
    {
      "key": "9498_CR15",
      "unstructured": "Kreienberg R, Kopp I, Albert U et al. (2008) Interdisziplinare S3-leitlinie fur die diagnostik, therapie und nachsorge des mammakarzinoms. Munich, W. Zuckschwerdt Verlag GmbH"
    },
    {
      "DOI": "10.1002/cncr.26428",
      "doi-asserted-by": "crossref",
      "key": "9498_CR16",
      "unstructured": "Bayraktar S, Elsayegh N, Gutierrez Barrera AM et al. (2011) Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ. Cancer"
    },
    {
      "DOI": "10.1200/JCO.2002.02.130",
      "author": "C Cremin",
      "doi-asserted-by": "crossref",
      "first-page": "3936",
      "issue": "18",
      "journal-title": "J Clin Oncol",
      "key": "9498_CR17",
      "unstructured": "Cremin C, Wong N, Buzaglo K, Paradis AJ, Foulkes W (2002) Nonovarian pelvic cancers in BRCA1/2 mutation carriers and the BRCAPRO statistical model. J Clin Oncol 20(18):3936",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.2307/2531595",
      "author": "ER DeLong",
      "doi-asserted-by": "crossref",
      "first-page": "837",
      "issue": "3",
      "journal-title": "Biometrics",
      "key": "9498_CR18",
      "unstructured": "DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845",
      "volume": "44",
      "year": "1988"
    },
    {
      "DOI": "10.1136/jmg.2007.056556",
      "author": "AC Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "425",
      "issue": "7",
      "journal-title": "J Med Genet",
      "key": "9498_CR19",
      "unstructured": "Antoniou AC, Hardy R, Walker L et al (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad, the Manchester scoring system using data from UK genetics clinics. J Med Genet 45(7):425–431",
      "volume": "45",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2008.16.8310",
      "author": "AW Kurian",
      "doi-asserted-by": "crossref",
      "first-page": "4752",
      "issue": "29",
      "journal-title": "J Clin Oncol",
      "key": "9498_CR20",
      "unstructured": "Kurian AW, Gong GD, Chun NM et al (2008) Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol 26(29):4752–4758",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10689-007-9150-z",
      "author": "NM Lindor",
      "doi-asserted-by": "crossref",
      "first-page": "473",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "9498_CR21",
      "unstructured": "Lindor NM, Lindor RA, Apicella C et al (2007) Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models. Fam Cancer 6(4):473–482",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.bjc.6603358",
      "author": "HH Kang",
      "doi-asserted-by": "crossref",
      "first-page": "914",
      "issue": "7",
      "journal-title": "Br J Cancer",
      "key": "9498_CR22",
      "unstructured": "Kang HH, Williams R, Leary J, Ringland C, Kirk J, Ward R (2006) Evaluation of models to predict BRCA germline mutations. Br J Cancer 95(7):914–920",
      "volume": "95",
      "year": "2006"
    },
    {
      "DOI": "10.1186/1471-2350-9-116",
      "author": "SM Panchal",
      "doi-asserted-by": "crossref",
      "first-page": "116",
      "journal-title": "BMC Med Genet",
      "key": "9498_CR23",
      "unstructured": "Panchal SM, Ennis M, Canon S, Bordeleau LJ (2008) Selecting a BRCA risk assessment model for use in a familial cancer clinic. BMC Med Genet 9:116",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1097/CEJ.0b013e32801023b3",
      "author": "PA Fasching",
      "doi-asserted-by": "crossref",
      "first-page": "216",
      "issue": "3",
      "journal-title": "Eur J Cancer Prev",
      "key": "9498_CR24",
      "unstructured": "Fasching PA, Bani MR, Nestle-Kramling C et al (2007) Evaluation of mathematical models for breast cancer risk assessment in routine clinical use. Eur J Cancer Prev 16(3):216–224",
      "volume": "16",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.maturitas.2007.02.013",
      "author": "MW Beckmann",
      "doi-asserted-by": "crossref",
      "first-page": "56",
      "issue": "1",
      "journal-title": "Maturitas",
      "key": "9498_CR25",
      "unstructured": "Beckmann MW, Bani MR, Fasching PA, Strick R, Lux MP (2007) Risk and risk assessment for breast cancer: molecular and clinical aspects. Maturitas 57(1):56–60",
      "volume": "57",
      "year": "2007"
    },
    {
      "DOI": "10.1158/0008-5472.SABCS-09-4073",
      "doi-asserted-by": "crossref",
      "key": "9498_CR26",
      "unstructured": "Kast K, Schmutzler RK, Distler W et al. (2009) Prevalence rates of pathogenic mutations in the BRCA1 and BRCA2 genes in families with different disease histories: results from the German consortium for hereditary breast and ovarian cancer. Cancer Res 69(24):731S-S"
    },
    {
      "DOI": "10.1006/gyno.1998.5270",
      "author": "J Backe",
      "doi-asserted-by": "crossref",
      "first-page": "402",
      "issue": "3",
      "journal-title": "Gynecol Oncol",
      "key": "9498_CR27",
      "unstructured": "Backe J, Hofferbert S, Skawran B et al (1999) Frequency of BRCA1 mutation 5382insC in German breast cancer patients. Gynecol Oncol 72(3):402–406",
      "volume": "72",
      "year": "1999"
    },
    {
      "DOI": "10.1038/ng1096-185",
      "author": "BB Roa",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "issue": "2",
      "journal-title": "Nat Genet",
      "key": "9498_CR28",
      "unstructured": "Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1, BRCA2. Nat Genet 14(2):185–187",
      "volume": "14",
      "year": "1996"
    },
    {
      "DOI": "10.1007/s12038-009-0048-9",
      "author": "K Vaidyanathan",
      "doi-asserted-by": "crossref",
      "first-page": "415",
      "issue": "3",
      "journal-title": "J Biosci",
      "key": "9498_CR29",
      "unstructured": "Vaidyanathan K, Lakhotia S, Ravishankar HM, Tabassum U, Mukherjee G, Somasundaram K (2009) BRCA1, BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations, high-frequency occurrence of 185delAG mutation. J Biosci 34(3):415–422",
      "volume": "34",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cncr.11533",
      "author": "LG Mullineaux",
      "doi-asserted-by": "crossref",
      "first-page": "597",
      "issue": "3",
      "journal-title": "Cancer",
      "key": "9498_CR30",
      "unstructured": "Mullineaux LG, Castellano TM, Shaw J et al (2003) Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado. Cancer 98(3):597–602",
      "volume": "98",
      "year": "2003"
    },
    {
      "DOI": "10.1038/ejhg.2010.29",
      "author": "I Zanna",
      "doi-asserted-by": "crossref",
      "first-page": "856",
      "issue": "7",
      "journal-title": "Eur J Hum Genet",
      "key": "9498_CR31",
      "unstructured": "Zanna I, Rizzolo P, Sera F et al (2010) The BRCAPRO 5.0 model is a useful tool in genetic counseling, clinical management of male breast cancer cases. Eur J Hum Genet 18(7):856–858",
      "volume": "18",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10549-010-0817-z",
      "author": "MD Sluiter",
      "doi-asserted-by": "crossref",
      "first-page": "325",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9498_CR32",
      "unstructured": "Sluiter MD, van Rensburg EJ (2011) Large genomic rearrangements of the BRCA1, BRCA2 genes: review of the literature, report of a novel BRCA1 mutation. Breast Cancer Res Treat 125(2):325–349",
      "volume": "125",
      "year": "2011"
    },
    {
      "DOI": "10.1002/humu.20723",
      "author": "S Engert",
      "doi-asserted-by": "crossref",
      "first-page": "948",
      "issue": "7",
      "journal-title": "Hum Mutat",
      "key": "9498_CR33",
      "unstructured": "Engert S, Wappenschmidt B, Betz B et al (2008) MLPAscreening in the BRCA1 gene from 1, 506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, occurrence in single early-onset cases. Hum Mutat 29(7):948–958",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1093/annonc/mdm233",
      "author": "S Veschi",
      "doi-asserted-by": "crossref",
      "first-page": "vi86",
      "issue": "6",
      "journal-title": "Ann Oncol",
      "key": "9498_CR34",
      "unstructured": "Veschi S, Aceto G, Scioletti AP et al (2007) High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. Ann Oncol 18(6):vi86–vi92",
      "volume": "18",
      "year": "2007"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-011-9498-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families"
  ],
  "type": "journal-article",
  "volume": "11"
}